165 related articles for article (PubMed ID: 32790146)
41. The treatment of craniopharyngiomas.
Lichter AS; Wara WM; Sheline GE; Townsend JJ; Wilson CB
Int J Radiat Oncol Biol Phys; 1977; 2(7-8):675-83. PubMed ID: 408309
[No Abstract] [Full Text] [Related]
42. Childhood-onset Craniopharyngioma.
Otte A; Müller HL
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3820-e3836. PubMed ID: 34086900
[TBL] [Abstract][Full Text] [Related]
43. [Craniopharyngioma in children: importance of a multidisciplinary approach and therapeutic strategies in the treatment of relapsing].
Fiorito CM; Giglione E; Bellone S; Peretta P; Bertin D; Basso ME; Bona G
Minerva Pediatr; 2013 Dec; 65(6):673-6. PubMed ID: 24217636
[TBL] [Abstract][Full Text] [Related]
44. Sleeve gastrectomy leads to easy management of hormone replacement therapy and good weight loss in patients treated for craniopharyngioma.
Trotta M; Da Broi J; Salerno A; Testa RM; Marinari GM
Updates Surg; 2017 Mar; 69(1):95-99. PubMed ID: 28260180
[TBL] [Abstract][Full Text] [Related]
45. Craniopharyngioma in Pediatrics and Adults.
Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
[TBL] [Abstract][Full Text] [Related]
46. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma.
Müller HL; Merchant TE; Puget S; Martinez-Barbera JP
Nat Rev Endocrinol; 2017 May; 13(5):299-312. PubMed ID: 28155902
[TBL] [Abstract][Full Text] [Related]
47. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP).
Howard SC; Davidson A; Luna-Fineman S; Israels T; Chantada G; Lam CG; Hunger SP; Bailey S; Ribeiro RC; Arora RS; Pedrosa F; Harif M; Metzger ML
Pediatr Blood Cancer; 2017 Dec; 64 Suppl 5():. PubMed ID: 29297619
[TBL] [Abstract][Full Text] [Related]
48. Childhood craniopharyngioma: Vancouver experience.
Hukin J; Visser J; Sargent M; Goddard K; Fryer C; Steinbok P
Childs Nerv Syst; 2005 Aug; 21(8-9):758-65. PubMed ID: 15959732
[TBL] [Abstract][Full Text] [Related]
49. National UK guidelines for the management of paediatric craniopharyngioma.
Gan HW; Morillon P; Albanese A; Aquilina K; Chandler C; Chang YC; Drimtzias E; Farndon S; Jacques TS; Korbonits M; Kuczynski A; Limond J; Robinson L; Simmons I; Thomas N; Thomas S; Thorp N; Vargha-Khadem F; Warren D; Zebian B; Mallucci C; Spoudeas HA
Lancet Diabetes Endocrinol; 2023 Sep; 11(9):694-706. PubMed ID: 37549682
[TBL] [Abstract][Full Text] [Related]
50. [Craniopharyngioma: ophthalmological manifestations and prognosis after treatment].
Dejardin V; Jaumain P; Stragier A; Boschi A
Bull Soc Belge Ophtalmol; 1999; 271():85-90. PubMed ID: 10355164
[TBL] [Abstract][Full Text] [Related]
51. Creative and Innovative Methods and Techniques for the Challenges in the Management of Adult Craniopharyngioma.
Takami H; Velásquez C; Asha MJ; Oswari S; Almeida JP; Gentili F
World Neurosurg; 2020 Oct; 142():601-610. PubMed ID: 32987616
[TBL] [Abstract][Full Text] [Related]
52. Long-term visual outcomes of craniopharyngioma in children.
Wan MJ; Zapotocky M; Bouffet E; Bartels U; Kulkarni AV; Drake JM
J Neurooncol; 2018 May; 137(3):645-651. PubMed ID: 29344823
[TBL] [Abstract][Full Text] [Related]
53. Multimodal treatment of craniopharyngioma: defining a risk-adapted strategy.
Puget S; Grill J; Habrand JL; Sainte-Rose C
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():367-70. PubMed ID: 16700312
[TBL] [Abstract][Full Text] [Related]
54. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
Pereira AM; Schmid EM; Schutte PJ; Voormolen JH; Biermasz NR; van Thiel SW; Corssmit EP; Smit JW; Roelfsema F; Romijn JA
Clin Endocrinol (Oxf); 2005 Feb; 62(2):197-204. PubMed ID: 15670196
[TBL] [Abstract][Full Text] [Related]
55. Analysis of Prognostic Factors, Extent of Resection, and Long-Term Outcome of Craniopharyngioma in Adults and Children.
Sadashivam S; Menon G; Abraham M; Nair SN
Neurol India; 2022; 70(5):2021-2030. PubMed ID: 36352604
[TBL] [Abstract][Full Text] [Related]
56. [Pediatric craniopharyngioma: long-term results in 61 cases].
Pancucci G; Massimi L; Caldarelli M; D'Angelo L; Sturiale C; Tamburrini G; Tufo T; Di Rocco C
Minerva Pediatr; 2007 Jun; 59(3):219-31. PubMed ID: 17519867
[TBL] [Abstract][Full Text] [Related]
57. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.
Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
Med Pediatr Oncol; 2003 Apr; 40(4):214-8. PubMed ID: 12555247
[TBL] [Abstract][Full Text] [Related]
58. [Therapeutic update on the treatment of craniopharyngiomas].
Bordallo MA; Ferreira RM; Bulzico DA
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):520-7. PubMed ID: 22218432
[TBL] [Abstract][Full Text] [Related]
59. Vascular complications in pediatric craniopharyngioma patients: a case-based update.
Sandvik U; Ohlsson M; Edström E
Childs Nerv Syst; 2019 Dec; 35(12):2273-2278. PubMed ID: 31667536
[TBL] [Abstract][Full Text] [Related]
60. More or less? Treatment strategies in childhood craniopharyngioma.
Müller HL
Childs Nerv Syst; 2006 Feb; 22(2):156-7. PubMed ID: 16320024
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
